It was a pleasure to speak at Celltrion’s ‘IBD Masterclass’ 📚
With keynotes from Prof Limdi and Dr Phil Smith and a wonderful multi-disciplinary attendance, it really was a great evening.
Thank you @Celltrionhc . 💉💊🏥
#IBD #UC #Crohnsdisease #CCUK #gastroenterologist
#IBD Market Size, Share & Growth Analysis To 2028
By Disease Indication ( #crohnsdisease , Ulcerative Colitis
Read more: tinyurl.com/3zvkhnzb
Major Player: AbbVie US Biogen Johnson & Johnson Amgen 🧪🔬🧬 Novartis Pfizer Inc. @Celltrionhc Allergan Eye Care Merck Novartis
We have come close to the end of 2023, marking another year of #BreakingTheBoundaries . 2023 was full of milestones that will guide us next year.
Here are some of this year's highlights we wanted to share with you.
Thank you all for joining us on our journey.😊💝
Greetings and Happy Holidays from all of us at #CelltrionHealthcare !
As the Spirit of the Season fills the air, our colleagues around the world would like to extend our warmest holiday greetings and express our heartfelt gratitude for being with us.
#HappyHolidays !✨🎁
Colleagues from Celltrion USA visited #Celltrion HQ, sharing insights and forging stronger connections.
We will continue breaking through boundaries to improve the quality of lives of people in the US by providing high-quality medicines and making US healthcare more accessible.
Had an amazing day @cpcongress #cpc23 #pharmacy #pharmacist #conference
Marvin Munzu
GSK Pfizer Inc.
@Celltrionhc
Chiesi Group
#Hameln
#morph MORPh Training - Primary Care Pharmacy Network
#bd
Siddiqur Rahman 💙 💚 🇵🇸
@Omnicell_UK
#stada STADA
#galapagos Galapagos #cpcongress
Faculty for Nursing Management in Chronic Disease meeting in CHB to share the career pathways open to nursing & management options for patients. Positive feedback from patients on impact of new treatment options #Biosimilars #Rheumatology #IBD #Dermatology @Celltrionhc
It was an absolute delight to attend two remarkable meetings in Jeju island in Korea. Fruitful discussions at the ASUC in Asia-Pacific symposium on collaborative research with Australia New Zealand IBD Consortium (ANZIBDC) and #AOCC . Sharing important clinical trials and RWE data at @Celltrionhc Remsima symposium.